These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 20497244

  • 1. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer.
    Gossage L, Zaitoun A, Fareed KR, Turley H, Aloysius M, Lobo DN, Harris AL, Madhusudan S.
    Histopathology; 2010 Jun; 56(7):908-20. PubMed ID: 20497244
    [Abstract] [Full Text] [Related]

  • 2. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
    Chen YR, Dai AG, Hu RC.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
    [Abstract] [Full Text] [Related]

  • 3. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
    Peurala E, Koivunen P, Bloigu R, Haapasaari KM, Jukkola-Vuorinen A.
    Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
    Xue J, Li X, Jiao S, Wei Y, Wu G, Fang J.
    Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
    [Abstract] [Full Text] [Related]

  • 6. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Kronqvist P, Jaakkola PM.
    Clin Cancer Res; 2006 Feb 15; 12(4):1080-7. PubMed ID: 16489060
    [Abstract] [Full Text] [Related]

  • 7. Low expression of prolyl hydroxylase 2 is associated with tumor grade and poor prognosis in patients with colorectal cancer.
    Xie G, Zheng L, Ou J, Huang H, He J, Li J, Pan F, Liang H.
    Exp Biol Med (Maywood); 2012 Jul 15; 237(7):860-6. PubMed ID: 22802519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT, Riedel J, Diem T, Wenner J, Flamme I, Pouyseggur J, Plate KH, Acker T.
    Cancer Res; 2010 Jan 01; 70(1):357-66. PubMed ID: 20028863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
    Andersen S, Donnem T, Stenvold H, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM.
    PLoS One; 2011 Jan 01; 6(8):e23847. PubMed ID: 21887331
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
    Sasada T, Azuma K, Hirai T, Hashida H, Kanai M, Yanagawa T, Takabayashi A.
    Ann Surg Oncol; 2008 Feb 01; 15(2):609-17. PubMed ID: 18026799
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.